LIFE SCIENCE, LAW AND BUSINESS

The third issue of Legalease's zappy little bimonthly Life Sciences, Law & Business has now been published. It contains, among other things, the following features:



* "IP Valuation -- Evaluation in Phamaceutical Projects" by PricewaterhouseCoopers' Lucinda Spicer and Jo Pisani (or should that be LucindaspicerandJopisani?);

* "Multi-party Actions -- Who Pays the Costs?" by Anna McKay (Roiter Zucker);

* "Global Healthcare -- TRIPs and Access to Medicines" by veteran patent expert Philip Grubb (Novartis International).



The IPKat says "enjoy".